New findings show programmable biomaterials can be delivered using needle injection to induce an immune response and fight deadly diseases
One of the reasons cancer is so deadly is that it can evade attack from the body’s immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard’s School of Engineering and Applied Sciences (SEAS) show a non–surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology.
“We can create 3D structures using minimally–invasive delivery to enrich and activate a host’s immune cells to target and attack harmful cells in vivo,” said the study’s senior author David Mooney, Ph.D., who is a Wyss Institute Core Faculty member and the Robert P. Pinkas Professor of Bioengineering at Harvard SEAS.
Tiny biodegradable rod–like structures made from silica, known as mesoporous silica rods (MSRs), can be loaded with biological and chemical drug components and then delivered by needle just underneath the skin. The rods spontaneously assemble at the vaccination site to form a three–dimensional scaffold, like pouring a box of matchsticks into a pile on a table. The porous spaces in the stack of MSRs are large enough to recruit and fill up with dendritic cells, which are “surveillance” cells that monitor the body and trigger an immune response when a harmful presence is detected.
“Nano–sized mesoporous silica particles have already been established as useful for manipulating individual cells from the inside, but this is the first time that larger particles, in the micron–sized range, are used to create a 3D in vivo scaffold that can recruit and attract tens of millions of immune cells,” said co-lead author Jaeyun Kim, Ph.D., an Assistant Professor of Chemical Engineering at Sungkyunkwan University and a former Wyss Institute Postdoctoral Fellow.
Synthesized in the lab, the MSRs are built with small holes, known as nanopores, inside. The nanopores can be filled with specific cytokines, oligonucleotides, large protein antigens, or any variety of drugs of interest to allow a vast number of possible combinations to treat a range of infections.
“Although right now we are focusing on developing a cancer vaccine, in the future we could be able to manipulate which type of dendritic cells or other types of immune cells are recruited to the 3D scaffold by using different kinds of cytokines released from the MSRs,” said co-lead author Aileen Li, a graduate student pursuing her Ph.D. in bioengineering at Harvard SEAS. “By tuning the surface properties and pore size of the MSRs, and therefore controlling the introduction and release of various proteins and drugs, we can manipulate the immune system to treat multiple diseases.”
The Latest on: Injectable 3D vaccines
[google_news title=”” keyword=”Injectable 3D vaccines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Injectable 3D vaccines
- Large Injection Site Reactions After a Second Dose of Varicella Vaccineon May 2, 2024 at 5:00 pm
and erythema at the injection site 24 hours after receiving a second dose of monovalent varicella vaccine. During this same time period, the clinic administered 143 doses of MMRV vaccine and 729 ...
- MRNA vaccine effective in treating glioblastoma brain cancer in small trialon May 2, 2024 at 9:24 am
An experimental cancer vaccine can quickly reprogram a person's immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found.
- Personalised mRNA vaccines: a revolutionary new approach in melanoma treatmenton May 2, 2024 at 8:46 am
Personalised mRNA vaccines represent a paradigm shift in cancer therapy – offering a highly targeted and adaptable approach to treatment. By harnessing the body’s immune system to selectively target ...
- Measles and rubella vaccine delivered via microarray patch shows promising resultson April 29, 2024 at 9:59 pm
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
- COVID-19 vaccines: Get the factson April 17, 2024 at 5:45 am
In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...
- Vaccine breakthrough means no more chasing strainson April 14, 2024 at 5:00 pm
With one vaccine injection, they found the mice were protected from a lethal dose of the unmodified virus for at least 90 days. Note that some studies show nine mouse days are roughly equivalent ...
- Does Pet Insurance Cover Vaccinations?on April 9, 2024 at 5:00 pm
For an additional monthly fee, you can add routine care coverage to your base policy to help pay for your pet’s wellness care, including vaccinations. Pets may need other injections, such as ...
- Experts in Industry Wrangle Over Whether Combo Vaccines Are Beneficial for Adultson April 3, 2024 at 5:00 pm
In considering the "value proposition" of combination vaccines for adults, one should look at the injection burden and current vaccine schedule, he said. Children receive approximately 27 separate ...
- Must mRNA be cloaked in a lipid coat to serve as a vaccine?on April 2, 2024 at 4:59 pm
Schematic diagram illustrating jet injection of a "Naked mRNA" vaccine. (Image: Satoshi Uchida) During the COVID-19 pandemic, mRNA vaccines have proven to be highly effective, with billions of doses ...
- Developing a vaccine for the 'zombie drug' xylazineon April 2, 2024 at 4:59 pm
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people. Xylazine is an FDA-approved sedative and pain ...
via Bing News